Category: Disease Discoveries
-
Study Provides Insights into the Development of Alzheimer’s
A rare genetic mutation found in patients with Alzheimer’s may provide further insight into the pathologic mechanisms that cause the disease.
-
Improving Immunotherapy For Breast Cancer
Treatment-resistant breast cancer could be made vulnerable to immunotherapy by flipping a metabolic “switch,” according to a new Northwestern Medicine study.
-
Using Stem Cells for Drug Discovery
A group of scientists combined medicinal chemistry and human stem cells to improve a medication treating a cardiac rhythm disorder, a strategy that could be applied broadly.
-
Staying in Contact: Health Investigators Track COVID-19 Cases
The COVID-19 contact tracing process, led by health departments across the state, and coordinated by the Illinois Department of Public Health, involves a team of dedicated team members tracking the spread of the disease.
-
Uncovering Racial Differences in Genomic Profiles of Prostate Cancer
A new study found that Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, highlighting the significance genetic drivers have in increasing one’s risk for developing aggressive prostate cancer.
-
Source of Rare Intellectual Disability Syndrome Discovered
New findings have revealed previously unknown information about the genetic basis for Armfield XLID syndrome, a rare intellectual disability linked to genetic defects in the X chromosome.
-
Inflammation Linked to Alzheimer’s
A new study provides a missing link between inflammation and protein deposits that contribute to Alzheimer’s disease.
-
‘Snowflake’ Nanoparticle Boosts Cancer Therapy
A snowflake-shaped nanoparticle greatly enhanced the combination of radiotherapy and immunotherapy in mouse models of prostate cancer.
-
Protein Paves the Way for Early HIV Infection
Northwestern Medicine investigators have discovered that a specialized protein associated with the microtubules of a cell helps facilitate and regulate early stages of HIV infection.
-
New Drug Target for Treatment-Resistant Prostate Cancer
Inhibiting an epigenetic regulator called DOT1L could be a key to slowing treatment-resistant prostate cancer, according to a recent Northwestern Medicine study.
